Antiviral pills could change pandemic's course

Science. 2021 Nov 12;374(6569):799-800. doi: 10.1126/science.acx9605. Epub 2021 Nov 11.
No abstract available

Publication types

  • News

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • Clinical Trials as Topic
  • Coronavirus Protease Inhibitors / administration & dosage
  • Coronavirus Protease Inhibitors / pharmacology
  • Coronavirus Protease Inhibitors / therapeutic use*
  • Cytidine / administration & dosage
  • Cytidine / analogs & derivatives
  • Cytidine / pharmacology
  • Cytidine / therapeutic use
  • Humans
  • Hydroxylamines / administration & dosage
  • Hydroxylamines / pharmacology
  • Hydroxylamines / therapeutic use
  • Lactams / administration & dosage
  • Lactams / pharmacology
  • Lactams / therapeutic use*
  • Leucine / administration & dosage
  • Leucine / pharmacology
  • Leucine / therapeutic use*
  • Nitriles / administration & dosage
  • Nitriles / pharmacology
  • Nitriles / therapeutic use*
  • Proline / administration & dosage
  • Proline / pharmacology
  • Proline / therapeutic use*
  • Ritonavir / administration & dosage
  • Ritonavir / pharmacology
  • Ritonavir / therapeutic use*
  • SARS-CoV-2 / drug effects
  • Tablets

Substances

  • Antiviral Agents
  • Coronavirus Protease Inhibitors
  • Hydroxylamines
  • Lactams
  • Nitriles
  • Tablets
  • nirmatrelvir and ritonavir drug combination
  • Cytidine
  • Proline
  • Leucine
  • Ritonavir
  • molnupiravir